5-((1H-indol-3-yl)methyl)-3-(3'-methylbiphenyl-3-yl)-1,2,4-oxadiazole

ID: ALA3759304

PubChem CID: 127027705

Max Phase: Preclinical

Molecular Formula: C24H19N3O

Molecular Weight: 365.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2cccc(-c3noc(Cc4c[nH]c5ccccc45)n3)c2)c1

Standard InChI:  InChI=1S/C24H19N3O/c1-16-6-4-7-17(12-16)18-8-5-9-19(13-18)24-26-23(28-27-24)14-20-15-25-22-11-3-2-10-21(20)22/h2-13,15,25H,14H2,1H3

Standard InChI Key:  OAVHUARNXZTWIV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    3.6552   -2.9294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2542   -4.2907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7448   -4.1226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0456   -2.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7409   -1.9129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4119   -2.0324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6896   -2.8088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0047   -2.0874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0375   -0.5877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7552    0.1905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4400   -0.5309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2877   -2.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2573   -4.3657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5409   -5.1419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8549   -4.4184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8853   -2.9187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6017   -2.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5166   -6.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1855   -2.6254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 14 18  1  0
 19  1  1  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 28 23  1  0
 20 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3759304

    ---

Associated Targets(Human)

PTPN1 Tchem Protein-tyrosine phosphatase 1B (8528 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPN2 Tchem T-cell protein-tyrosine phosphatase (1317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPN6 Tchem Protein-tyrosine phosphatase 1C (687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPN11 Tchem Protein-tyrosine phosphatase 2C (2297 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPRF Tchem Receptor-type tyrosine-protein phosphatase F (LAR) (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 365.44Molecular Weight (Monoisotopic): 365.1528AlogP: 5.78#Rotatable Bonds: 4
Polar Surface Area: 54.71Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.44CX LogD: 6.44
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: -1.33

References

1. Zhang L, Jiang CS, Gao LX, Gong JX, Wang ZH, Li JY, Li J, Li XW, Guo YW..  (2016)  Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.,  26  (3): [PMID:26774579] [10.1016/j.bmcl.2015.12.097]
2. Malamas, M S MS and 7 more authors.  2000-03-09  New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.  [PMID:10715163]
3. Malamas, M S MS and 10 more authors.  2000-04-06  Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.  [PMID:10753467]
4. Andersen, Henrik Sune HS and 19 more authors.  2002-09-26  Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.  [PMID:12238924]
5. Lee, Kyeong K and 8 more authors.  2003-08-04  Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase.  [PMID:12852970]
6. Dufresne, Claude C and 16 more authors.  2004-02-23  The development of potent non-peptidic PTP-1B inhibitors.  [PMID:15013019]
7. Wilson, Douglas P DP and 20 more authors.  2007-09-20  Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.  [PMID:17705360]
8. Han, Yongxin Y and 14 more authors.  2008-06-01  Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor.  [PMID:18477508]
9. Hussain, Munawar M, Ahmed, Vanessa V, Hill, Bryan B, Ahmed, Zaheer Z and Taylor, Scott D SD.  2008-07-15  A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition.  [PMID:18555687]
10. Zhang, Yi-Nan YN and 7 more authors.  2008-09-15  Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.  [PMID:18707891]
11. Shrestha, Suja S, Bhattarai, Bharat Raj BR, Kafle, Bhooshan B, Lee, Keun-Hyeung KH and Cho, Hyeongjin H.  2008-09-15  Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity.  [PMID:18722777]
12. Lin, Li L, Shen, Qiang Q, Chen, Guo-Rong GR and Xie, Juan J.  2008-11-15  Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.  [PMID:18922697]
13. Forghieri, Marco M and 8 more authors.  2009-04-01  Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.  [PMID:19297174]
14. Vidović, Dusica and Schürer, Stephan C.  2009-11-12  Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.  [PMID:19810703]
15. Wu, Shuangding S and 14 more authors.  2009-11-12  Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.  [PMID:19888758]
16. and Combs, Andrew P AP.  2010-03-25  Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.  [PMID:20000419]
17. Lantz, Kristen A KA and 6 more authors.  2010-08  Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice.  [PMID:20075852]
18. Cheng, Yuanhua Y, Zhou, Mei M, Tung, Chen-Ho CH, Ji, Mingjuan M and Zhang, Fushi F.  2010-06-01  Studies on two types of PTP1B inhibitors for the treatment of type 2 diabetes: Hologram QSAR for OBA and BBB analogues.  [PMID:20452766]
19. Xu, Ji-Qing JQ, Shen, Qiang Q, Li, Jia J and Hu, Li-Hong LH.  2010-06-01  Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B.  [PMID:20472439]
20. Comeau, Anthony B AB, Critton, David A DA, Page, Rebecca R and Seto, Christopher T CT.  2010-09-23  A focused library of protein tyrosine phosphatase inhibitors.  [PMID:20731359]
21. Vang, Torkel T and 15 more authors.  2011-01-27  Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.  [PMID:21190368]
22. Scott, Latanya M and 8 more authors.  2011-01-15  Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.  [PMID:21193311]
23. He, Yantao Y and 5 more authors.  2012-03-15  Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.  [PMID:22133902]
24. He, Hai-Bing HB and 9 more authors.  2012-12-01  Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.  [PMID:23067554]
25. Shi, Dayong D and 6 more authors.  2013-01-30  HPN, a synthetic analogue of bromophenol from red alga Rhodomela confervoides: synthesis and anti-diabetic effects in C57BL/KsJ-db/db mice.  [PMID:23364683]
26. Chen, Yue-Ting YT and 8 more authors.  2013-11  Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.  [PMID:24090912]
27. Ottanà, Rosaria R and 8 more authors.  2014-01  Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.  [PMID:24287560]
28. Nguyen, Phi-Hung PH and 6 more authors.  2015-01-23  Insulin-mimetic selaginellins from Selaginella tamariscina with protein tyrosine phosphatase 1B (PTP1B) inhibitory activity.  [PMID:25559759]
29. Tautz, Lutz L, Senis, Yotis A YA, Oury, Cécile C and Rahmouni, Souad S.  2015-06-15  Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.  [PMID:25921264]
30. Abdjul, Delfly B DB and 6 more authors.  2015-06-26  Structures and Biological Evaluations of Agelasines Isolated from the Okinawan Marine Sponge Agelas nakamurai.  [PMID:26083682]
31. Kozakov, Dima and 5 more authors.  2015-12-10  New Frontiers in Druggability.  [PMID:26230724]
32. Wang, Mei-Yan MY and 9 more authors.  2015-10-20  Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.  [PMID:26342135]
33. Liu, Peihong P, Du, Yongli Y, Song, Lianhua L, Shen, Jingkang J and Li, Qunyi Q.  2015-11-01  Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.  [PMID:26481657]
34. Abdjul, Delfly B DB, Kanno, Syu-Ichi SI, Yamazaki, Hiroyuki H, Ukai, Kazuyo K and Namikoshi, Michio M.  2016-01-15  A dimeric urea of the bisabolene sesquiterpene from the Okinawan marine sponge Axinyssa sp. inhibits protein tyrosine phosphatase 1B activity in Huh-7 human hepatoma cells.  [PMID:26711144]
35. Liu, Peihong P, Du, Yongli Y, Song, Lianhua L, Shen, Jingkang J and Li, Qunyi Q.  2016-08-08  Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.  [PMID:27123900]
36. Li, XiangQian X, Wang, LiJun L and Shi, DaYong D.  2016-08-15  The design strategy of selective PTP1B inhibitors over TCPTP.  [PMID:27353889]
37. Tan, Xue Fei XF and 6 more authors.  2017-04-15  Competitive protein tyrosine phosphatase 1B (PTP1B) inhibitors, prenylated caged xanthones from Garcinia hanburyi and their inhibitory mechanism.  [PMID:28318895]
38. Li, Xiang-Qian XQ and 6 more authors.  2017-08-18  Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B.  [PMID:28511130]
39. Sun, Wenlong W and 6 more authors.  2017-08-01  Varic acid analogues from fungus as PTP1B inhibitors: Biological evaluation and structure-activity relationships.  [PMID:28642102]
40. Mascarello, Alessandra A and 13 more authors.  2018-01-20  Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B.  [PMID:29275228]
41. Pastor, Miryam M and 13 more authors.  2018-01-20  Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.  [PMID:29275231]
42. Du, Yongli Y, Zhang, Yanhui Y, Ling, Hao H, Li, Qunyi Q and Shen, Jingkang J.  2018-01-20  Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site.  [PMID:29289892]
43. Xie, Fangzhou F and 10 more authors.  2019-02-15  Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors.  [PMID:30611982]
44. Li, Xiangqian X and 7 more authors.  2019-03-15  Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.  [PMID:30711829]
45. Jin, Jia J and 6 more authors.  2019-08-15  Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).  [PMID:31221555]
46. Dowarah, Jayanta and Singh, Ved Prakash.  2020-03-01  Anti-diabetic drugs recent approaches and advancements.  [PMID:32008883]
47. Yuan, Xinrui; Bu, Hong; Zhou, Jinpei; Yang, Chao-Yie and Zhang, Huibin.  2020-10-22  Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.  [PMID:32460492]

Source